It's not just science: Challenges for public health intervention in Ebola epidemics in the Democratic Republic of Congo

Pengyan Wang^{1

2}, William J Liu^{3

4}

Affiliations

¹ School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
² NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
³ School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, China. liujun@ivdc.chinacdc.cn.
⁴ NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. liujun@ivdc.chinacdc.cn.

Review

Pengyan Wang et al. Sci China Life Sci. 2020 Jul.

. 2020 Jul;63(7):1079-1081.

doi: 10.1007/s11427-019-1670-6. Epub 2020 Mar 10.

Pengyan Wang^{1

2}, William J Liu^{3

4}

¹ School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
² NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
³ School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, China. liujun@ivdc.chinacdc.cn.
⁴ NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. liujun@ivdc.chinacdc.cn.

No abstract available

References

1. Gao, G.F. (2019). China’s outreach to the world: public health goes global. China CDC Weekly 1, 1–2. - DOI
1. Han, M., Gu, J., Gao, G.F., and Liu, W.J. (2017). China in action: National strategies to combat against emerging infectious diseases. Sci China Life Sci 60, 1383–1385. - DOI
1. Li, J.X., Hou, L.H., Meng, F.Y., Wu, S.P., Hu, Y.M., Liang, Q., Chu, K., Zhang, Z., Xu, J.J., Tang, R., et al. (2017). Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet glob Health 5, e324–e334. - DOI
1. Liu, W.J. (2016). On the ground in Western Africa: from the outbreak to the elapse of Ebola. Protein Cell 7, 621–623. - DOI
1. Mahase, E. (2019). Attacks on Ebola sites in DRC leave four workers dead. BMJ 367, 16750.